Skip to content

Effects of Repetitive Transcranial Magnetic Stimulation on Heart Rate Variability

Effects of Repetitive Transcranial Magnetic Stimulation on Heart Rate Variability

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03739489
Acronym
TMSXHRV
Enrollment
30
Registered
2018-11-13
Start date
2018-04-01
Completion date
2018-12-31
Last updated
2018-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Rate Variability

Keywords

healthy subjects, repetitive transcranial magnetic stimulation, heart rate variability

Brief summary

Repetitive transcranial magnetic stimulation is a non-invasive neuromodulation technique used to treat different neuropsychiatric disorders, such as, depression, neuropathic pain, fibromyalgia and obsessive-compulsive disorder. It is known that the heart rate variability is altered in these conditions. Therefore the focus of this research is to show the influence of rTMS on the Heart Rate Variability.

Interventions

PROCEDURERepetitive transcranial magnetic stimulation

Repetitive transcranial magnetic stimulation was a technique able to modulate the brain circuit restoring the function.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The participant will be received three different sessions of rtms, with wash out 30 days between sessions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Agreed participate the protocol * Signing the consent form * Do not present any cardiac problems or disease

Exclusion criteria

* Trauma of Skull, epilepsy don't treated, * Use of medications decrease the seizure threshold * Patients in use of drugs, how cocaine and alcohol * Neurosurgical clips, pacemakers, increased intracranial pressure (risk of sequelae after seizure) * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
Heart rate variability changesThree times during the entire study. Following the scheme, Until 1 hour before each session, 15 minutes along the each session and until 1 hour after the end of sessionChanges in heart rate variability measured by Polar V800

Secondary

MeasureTime frameDescription
Conditioned Pain Modulation48 hours before the first session of stimulationchange in pain units on a scale of 0-100. 0 no pain. 100 = the maximum pain
Volume in1 week before the first session of stimulationDetermine if volume cortical regions can serve as biomarkers to predict rTMS treatment response in Healthy volunteers

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026